Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5326_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
52 Мб
Скачать
Surface modication by natural biopolymer coatings on magnesium alloys 323
(a) (d)
(b)
(c)
Figure 11.16 SEM micrographs showing the surface of (a) SA1eMg, (b) SA2eMg, and (c) SA3eMg. Optical images showing surface appearance of samples after immersion in Hanks solution: (d) Bare Mg (6 days), (e) SA1eMg (6 days), and (f) SA2eMg (80 days).
(e)
(f)
The results from the SA coating work are encouraging; however, some problems still exist. Like lard coating on the surface of metals, it is hard for cells to attach on the surface. Also, although MgSt provided a bridge between Mg and SA, a binding force is suspected.
11.5 Gelatin modication
11.5.1 Introduction to gelatin
Gelatin is a proteinaceous material derived from naturally existing collagen by controlled hydrolysis. It is a substance of great commercial importance and always contains large amounts of proline and hydroxyproline as well as glycine. It also exists in other residues, includingpolar amino acids, which tend to occur in positiveand negativeclusters at points along the tropocollagen rod surface (Clark & Ross-Murphy, 1987). Due to its numerous
324 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
9
10
8
10
7
10
6
10
5
10
4
10
3
ratio (SA2-Mg / bare Mg)
10
t
R
2
10
1
10
02468101214
R
ratio
t
16 18 20 222426 28 30
Time (day)
pH
8.0
7.5
7.0
6.5
6.0
5.5
5.0
pH
Figure 11.17 Corrosion resistance of SA-coated sample (SA2eMg) relative to bare Mg in the immersion test. Adapted from Ng et al. (2010).
SA MgSt
Mg(OH)
2
HA OCP
After immersion
Intensity (a.u)
Before immersion
10 20 30 40
50 60 70 80
2θ (°)
Figure 11.18 XRD patterns of SA2eMg before and after immersion in Hankssolutionfor 80 days. Adapted from Ng et al. (2010).
advantages, such as its biological origin, biodegradability, and good biocompatibility, together with its commercial availability at a relatively low cost, gelatin has been widely used in biomedical applications. For example, it has long been used as a sealant for vascular prostheses, an artificial skin (Ponticiello, Schinagl, Kadiyala, & Barry, 2000), a carrier for drug delivery (Tabata & Ikada, 1998), and in regeneration therapy (Ponticiello
et al., 2000), among others (Zhang, Ouyang, Lim, Ramakrishna, & Huang, 2005).
Surface modication by natural biopolymer coatings on magnesium alloys 325
11.5.2 Gelatin coating on WE42 alloy
In the study by Xu, Lu, Guo, and Fang, (2010), a cross -linked gelatin with well­distributed PLGA nanoparticles composite coating on an MAO lm of WE42, which could control drug release and biocorrosion of magnesium alloy stent materials, was prepared by sealing microcracks and holes on the surface of the MAO coating. An equal volume of gelatin solution (6%) was mixed with different concentrations of glutaraldehyde solution (1%, 2%, 3%) to form different degrees of cross-linked gelatin solution. Three milligrams of paclitaxel-loaded nanoparticles fabricated by a modied oil-in-water single-emulsion solvent evaporation/extraction technique were mixed and sonicated with 400 m l of cross-linked gelatin solution. After being dried at room tem­perature, the cross-linked gelatin/nanoparticle solution was dropped onto the surface of MAO lm, and then the samples were dried at room temperature.
Figure 11.19 shows the surface morphologies of the MAO coating and cross-linked
gelatin/nanoparticles composite coating on the MAO coating. Randomly distributed molten oxide akes with pores and microcracks were observed on the MAO coating surface. After being modied by the cross-linked gelatin/nanosphere composite coating, most of the pores and microcracks of the MAO lm could be overlaid, form­ing a smooth and uniform composite coating. This composite coating has higher stability and better binding capacity due to the physical interlocking between the cross-linked gelatin/nanosphere composite and MAO lm.
Electrochemical tests were carried out in Hankssolution by potentiodynamic polar­ization curves and EIS. As shown in Figure 11.20, the higher the concentration of glutaraldehyde, the higher the transfer resistance Rp of the samples. The Rp of WE42-MAO-composite coating was much higher than that of WE42-MAO (Rp > 100 kU cm bare WE42 (3.5 kU cm lower corrosion current density than the sample with MAO coating and bare WE42 samples. These results indicated that the composite coating on WE42 served as an effective barrier against corrosive electrolyte, effectively improving the corrosion resis­tance of WE42.
An in vitro drug release test showed that a cross-linked gelatin/nanoparticles coating exhibited a nearly linear relationship with no signicant burst releases
2
), which was already more than 30 times higher than the Rp of the
2
). In addition, MAO-composite coated samples showed much
(a) (b)
Figure 11.19 The SEM images of (a) surface morphologies of MAO coating and (b) cross-linked gelatin/nanoparticles composite coating on MAO coating.
)
326 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
(Figure 11.21). In addition, the release rate of paclitax el decreased as the concentra­tion of the glutaraldehyde increased. This suggests that highly cross-linked gelatin could more effectively decrease the diffusion of the paclitaxel and water by swelling of the gelatin and hinder the release of paclitaxel from the PLGA nanoparticles.
A cross-linked gelatin/nanosphere composite coated WE42-MAO has increased
the corrosion resistance of WE42-MAO and controlled the drug release
(a)
–0.6
WE42-MAO-composite coating(glutaraldehyde 1%)
–0.8
–1.0
–1.2
–1.4
Potential (V)
–1.6
–1.8
–2.0
WE42-MAO-composite coating(glutaraldehyde 2%) WE42-MAO-composite coating(glutaraldehyde 3%) WE42 WE42-MAO
1E-9 1E-8 1E-7 1E-6 1E-5 1E-4 1E-3
A / cm
2
(b)
WE42-MAO-composite coating(glutaraldehyde 1%)
60000
40000
Zim (ohms)
20000
0
Figure 11.20 The electrochemical characteristics of MAO coating and cross-linked gelatin/ nanoparticles coating on the MAO lm in pH 7.4 Hankssolution at 37
WE42-MAO-composite coating(glutaraldehyde 2%) WE42-MAO-composite coating(glutaraldehyde 2%) WE42 WE42-MAO
0 50000 100000 150000
Zre (ohms
C.
Surface modication by natural biopolymer coatings on magnesium alloys 327
30
25
20
15
10
PTX release rate (%)
5
0
Figure 11.21 The in vitro release pattern of paclitaxel from different degrees of cross-linking gelatin/nanoparticles composite coating. Adapted from Xu et al. (2010).
PLGA nanoparticles PLGA nanoparticles(glutaraldehyde 1%) PLGA nanoparticles(glutaraldehyde 2%) PLGA nanoparticles(glutaraldehyde 3%)
01020
Release time (days)
30 40 50
of paclitaxel-loaded PLGA nanoparticles effectively. The higher the cross-linking rate, the better the corrosion protective ability and drug-release control properties.
11.6 Bovine serum albumin modication
11.6.1 Introduction to stearic bovine serum albumin
Serum albumins are the most abundant proteins in the circulatory system of various or­ganisms. As the major macromolecule related to the osmotic blood pressure, they play an important role in drug disposition and efcacy (Kamat, 2005). Many drugs and other bioactive small molecules bind reversibly to albumin and other serum components, which can be functionalized as carriers. The solubility of hydrophobic drugs in plasma can be increased by serum albumin, and their delivery to cells is modulated. Therefore, it is of great importance to study the interactions of drugs with this protein. The effective­ness of drugs depends on their binding ability (Hu, Liu, Wang, Xiao, & Qu, 2004).
11.6.2 Bovine serum albumin coating on magnesium
As reported by Liu Xin, Tian, and Chu, (2007b), the adsorbed bovine serum albumin (BSA) resulted in decreased cathodic current and enhanced corrosion resistance, which was ascribed to the blocking effect of the BSA-adsorbed layer, suggesting that the adsorbed BSA coverage layer can suppress the dissolution of magnesium alloys.
328 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Killian et al. (Killian, Wagener, Schmuki, & Virtanen, 2010) managed to prepare an albumi n- coa ted magnesium for comparative ly smooth surfaces via silane coupling chemistry. They used 3-aminopropyltriethoxy silane (APTES) as a silane coupling agent and ascorbic acid (vitamin C) worked as a linker for the grafting of BSA on the surface of the Mg substrate. BSA (400 unit/mL) was attached from aqueous solution by soaking ma gne siu m d iscs fo r 2 4 h at room tem pe ratu re u nde r stirring. The Mg samples steeped in albumin solution directly were used as controls.
Results of XPS and time-of-ight secondary ion mass spectrometry (ToF-SIMS) both showed an increased relative intensity of magnesium signals (Mg 2p; m/z ¼ 24
þ
u, Mg
) as well as a decrease in amino acid signals (N 1s; m/z ¼ 110 u, C5H8N
þ
, his-
3
tidine) on the steeped sample compa red with those of the pretreated magnesium surface (Figure 11.22(a) and (b)). This indicated a more homogeneous, dense coverage of the silane-coupled protein coating.
In Figure 11.23, the surface of the pretreated sample was smoother and contained fewer defects than the steeped one. Pretreatment in organic solutions had a suppressive effect on the formation of H
gas as a result of decreased availability of reactive sites.
2
This has led to a more uniformly coated surface that is less prone to corrosion. After being soaked in SBF for 2.5 days, the surface of the steeped sample was not only rougher after immersion in SBF but also exhibited larger holes because of localized corrosion. Meanwhile, the hydrogen evolution decreased signicantly from
0.12 mL/cm
2
/d for the polished sample to 0.075 mL/cm2/d after treatment with APTES (Figure 11.24), which also indicated that the albumin coatings attached via silane linkers on magnesium had higher corrosion resistance.
This procedure provides a simple and efcient way to attach proteins on the surface of magnesium alloys. Because the attachment was based on silane coupling chemistry on an OH-terminated surface, the approach should be applicable to a variety of proteins as well as to biocompatible magnesium alloys.
Figure 11.22 Comparison of albumin attached to pretreated Mg and Mg steeped in albumin solution. (a) XPS atomic percentages. (b) Time-of-ight secondary ion mass spectrometry (ToF-SIMS) ratio of histidine C Adapted from Killian et al. (2010).
þ
to magnesium Mgþ.
5H8N3
Surface modication by natural biopolymer coatings on magnesium alloys 329
(a)
(c)
(b)
(d)
(e) (f)
Figure 11.23 Optical images of (a) albumin attached via silane coupling on Mg and (b) Mg steeped in albumin solution. Light microscopy images of (c) albumin attached via silane coupling on Mg and (d) Mg steeped in albumin solution. Light microscopy images after 2.5 days of immersion in SBF for (e) albumin attached via silane coupling on Mg and (f) Mg steeped in albumin solution. Adapted from Killian et al. (2010).
11.7 Future perspectives
After surface modication by some natural biopolymer or macromolecules, the corro­sion property or biocompatibility of magnesium or its alloys have been greatly improved in these studies. However, literature reports about natural biopolymer modication mag­nesium alloys are limited. Because natural biopolymers are abundant, biocompatible, and bioactive, more potential applications of other kinds of natural biopolymers, such as alginate agar, hyaluronic acid, and cellulose, should be developed as coatings on mag­nesium alloys. Table 11.6 lists the commonly used natural biopolymers. These
330 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
0.2
0.1
[ml]
2
H
0.0
Mg polished
APTES
APTES + VitC
Albumin via APTES
Albumin direct
Figure 11.24 Hydrogen evolution measurements of all of the reaction stages after 24 h of immersion in SBF. Adapted from Killian et al. (2010).
Table 11.6 Natural biopolymers used as biomaterials
Natural biopolymers
Modied polysaccharides Alginate agar/agarose
Cellulose Hyaluronic acid
Starch Chondroitin sulfate
Dextran Fibroin
Chitin Gelatin
Modied proteins Chitosan
Collagen Casein
biopolymers are widely used in biomedical elds, such as delivery systems, cell carriers, and scaffolds for tissue engineering.
As for the manufacturing procedures, most of the coating preparations use a two-step method to create a bond between layers. Firstly, MAO or hydrothermal treatment is used to form an interlayer to get stronger binding force. Secondly, natural biopolymer modication is performed by dipping or other methods. However, adhesion tests for polymer or composite coatings have rarely been performed.
In addit ion, natural biopolymer-based coatings have shown the capability to act as local drug delivery platforms. However, only a few studies have focused on this topic, indicating that the development of these coatings is in its infancy.
Surface modication by natural biopolymer coatings on magnesium alloys 331
References
Beare-Rogers, J., Dieffenbacher, A., & Holm, J. (2001). Lexicon of lipid nutrition (IUPAC
technical report). Pure and Applied Chemistry, 73, 685e744.
Chen, Y., Song, Y., Zhang, S., Li, J., Zhao, C., & Zhang, X. (2011). Interaction between a high
purity magnesium surface and PCL and PLA coatings during dynamic degradation. Biomedical Materials, 6, 025005.
Cheryan, M., & Rackis, J. J. (1980). Phytic acid interactions in food systems. Critical Reviews in
Food Science & Nutrition, 13, 297e335.
Clark, A. H., & Ross-Murphy, S. B. (1987). Structural and mechanical properties of biopolymer
gels. Biopolymers (pp. 57e192). Berlin, Heidelberg: Springer.
Crea, P., De Robertis, A., De Stefano, C., & Sammartano, S. (2006). Speciation of phytate ion in
aqueous solution. Sequestration of magnesium and calcium by phytate at different tem­peratures and ionic strengths, in NaCl
Graf, E., Empson, K. L., & Eaton, J. W. (1987). Phytic acid. A natural antioxidant. Journal of
Biological Chemistry, 262, 11647e11650.
Gu, X., Li, N., Zhou, W., Zheng, Y., Zhao, X., Cai, Q., et al. (2011). Corrosion resistance and
surface biocompatibility of a microarc oxidation coating on a MgeCa alloy. Acta Biomaterialia, 7, 1880e1889.
Gu, X., Zheng, W., Cheng, Y., & Zheng, Y. (2009a). A study on alkaline heat treated MgeCa
alloy for the control of the biocorrosion rate. Acta Biomaterialia, 5, 2790e2799.
Gu, X., Zheng, Y., Lan, Q., Cheng, Y., Zhang, Z., Xi, T., et al. (2009b). Surface modication of an
Mg-1Ca alloy to slow down its biocorrosion by chitosan. Biomedical Materials, 4, 044109.
Hahn, B.-D., Park, D.-S., Choi, J.-J., Ryu, J., Yoon, W.-H., Choi, J.-H., et al. (2011). Aerosol
deposition of hydroxyapatitee chitosan composite coatings on biodegradable magnesium alloy. Surface and Coatings Technology, 205, 3112e3118.
Hornberger, H., Virtanen, S., & Boccaccini, A. R. (2012). Biomedical coatings on magnesium
alloys e a review. Acta Biomaterial, 8, 2442e2455.
Hu, Y.-J., Liu, Y., Wang, J.-B., Xiao, X.-H., & Qu, S.-S. (2004). Study of the interaction
between monoammonium glycyrrhizinate and bovine serum albumin. Journal of Phar- maceutical and Biomedical Analysis, 36, 915e919.
ISO, E., 10993e4. (2006). Biological evaluation of medical devices - Selection of tests for
interactions with blood.
Kamat, B. P. (2005). Study of the interaction between uoroquinolones and bovine serum
albumin. Journal of pharmaceutical and biomedical analysis, 39, 1046e1050.
Kelly, F., Sinclair, A., Mann, N., Turner, A., Abedin, L., & Li, D. (2001). A stearic acid-rich diet
improves thrombogenic and atherogenic risk factor proles in healthy males. European Journal of Clinical Nutrition, 55, 88.
Khor, E., & Lim, L. Y. (2003). Implantable applications of chitin and chitosan. Biomaterials, 24,
2339e2349.
Killian, M. S., Wagener, V., Schmuki, P., & Virtanen, S. (2010). Functionalization of metallic
magnesium with protein layers via linker molecules. Langmuir, 26, 12044e12048.
Li, J., Cao, P., Zhang, X., Zhang, S., & He, Y. (2010). In vitro degradation and cell attachment of
a PLGA coated biodegradable Mge 6Zn based alloy. Journal of Materials Science, 45, 6038e6045.
Liu, C., Xin, Y., Tian, X., & Chu, P. K. (2007a). Corrosion behavior of AZ91 magnesium alloy
treated by plasma immersion ion implantation and deposition in arti uids. Thin Solid Films, 516, 422e427.
. Biophysical Chemistry, 124,18e26.
aq
cial physiological
332 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Liu, C., Xin, Y., Tian, X., & Chu, P. K. (2007b). Degradation susceptibility of surgical
magnesium alloy in articial biological uid containing albumin. Journal of Materials Research, 22, 1806e1814.
Majeti, N. V. R. K. (2000). A review of chitin and chitosan applications. Reactive & Functional
Polymers, 46,1e27.
Ng, W. F., Wong, M. H., & Cheng, F. T. (2010). Stearic acid coating on magnesium for
enhancing corrosion resistance in Hankssolution. Surface and Coatings Technology, 204, 1823e1830.
Petit, R. (1999). The use of hydroxyapatite in orthopaedic surgery: a ten-year review. European
Journal of Orthopaedic Surgery & Traumatology, 9,71e74.
Ponticiello, M. S., Schinagl, R. M., Kadiyala, S., & Barry, F. P. (2000). Gelatin-based resorbable
sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. Journal of Biomedical Materials Research, 52, 246e255.
Ravi Kumar, M. N. (2000). A review of chitin and chitosan applications. Reactive and Func-
tional Polymers, 46,1e27.
Rinaudo, M. (2006). Chitin and chitosan: properties and applications. Progress in Polymer
Science, 31, 603e632.
Staiger, M. P., Pietak, A. M., Huadmai, J., & Dias, G. (2006). Magnesium and its alloys as
orthopedic biomaterials: a review. Biomaterials, 27, 1728e1734.
Tabata, Y., & Ikada, Y. (1998). Protein release from gelatin matrices. Advanced Drug Delivery
Reviews, 31, 287e301.
Tan, H., & Marra, K. G. (2010). Injectable, biodegradable hydrogels for tissue engineering
applications. Materials, 3, 1746e1767.
Tomozawa, M., & Hiromoto, S. (2011). Microstructure of hydroxyapatite-and octacalcium
phosphate-coatings formed on magnesium by a hydrothermal treatment at various pH values. Acta Materialia, 59, 355e363.
Wan, Y., Xiong, G., Luo, H., He, F., Huang, Y., & Wang, Y. (2008). Inuence of zinc ion
implantation on surface nanomechanical performance and corrosion resistance of biomedical magnesium-calcium alloys. Applied Surface Science, 254, 5514e5516.
Wang, X., Zeng, X., Wu, G., Yao, S., & Lai, Y. (2007). Effects of tantalum ion implantation on
the corrosion behavior of AZ31 magnesium alloys. Journal of Alloys and Compounds, 437, 87e92.
Wong, H. M., Yeung, K. W., Lam, K. O., Tam, V., Chu, P. K., Luk, K. D., et al. (2010).
A biodegradable polymer-based coating to control the performance of magnesium alloy orthopaedic implants. Biomaterials, 31, 2084e2096.
Wu, C., Wen, Z., Dai, C., Lu, Y., & Yang, F. (2010). Fabrication of calcium phosphate/chitosan
coatings on AZ91D magnesium alloy with a novel method. Surface and Coatings Tech- nology, 204, 3336
e3347.
Wu, G. S., Zeng, X. Q., Yao, S. S., & Han, H. B. (2007). Ion implanted AZ31 magnesium alloy.
Materials Science Forum, 546e549, 551.
Xu, X., Lu, P., Guo, M., & Fang, M. (2010). Cross-linked gelatin/nanoparticles composite
coating on micro-arc oxidation lm for corrosion and drug release. Applied Surface Sci- ence, 256, 2367e2371.
Ye, C., Zheng, Y., Wang, S., Xi, T., & Li, Y. (2012). In vitro corrosion and biocompatibility
study of phytic acid modied WE43 magnesium alloy. Applied Surface Science, 258, 3420e3427.
Yu, S., Derr, J., Etherton, T. D., & Kris-Etherton, P. (1995). Plasma cholesterol-predictive
equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. The American Journal of Clinical Nutrition, 61, 1129e1139.